Table 1 Demographics and comorbidities of the 216 included patients, and comparison according to the consumption of anti-inflammatory drugs prior to admission
Total population | No AID consumption | AID consumption | p-value | |
|---|---|---|---|---|
Demographics | 216 | 89 (41.2 %) | 127 (58.7 %) | |
Sex (male) | 119 (55.1 %) | 52 (58.4 %) | 67 (52.8 %) | 0.410 |
Age (years) | 32.2 (25.7–39.5) | 31.3 (25.6–38.9) | 32.8 (25.7–39.7) | 0.670 |
Comorbidities | ||||
BMI (kg/cm2) | 23.6 (21.7–26.5) | 25.1 (22.0–28.6) | 23.4 (20.6–25.8) | 0.091 |
Diabetes | 3 (1.4 %) | 3 (3.4 %) | 0 (0.0 %) | 0.069 |
Chronic respiratory disease | 2 (0.9 %) | 1 (1.1 %) | 1 (0.8 %) | 1.000 |
Pharyngitis | 24 (11.1 %) | 13 (14.6 %) | 11 (8.7 %) | 0.171 |
Peritonsillar suppuration | 16 (7.4 %) | 9 (10.1 %) | 7 (5.5 %) | 0.204 |
Immunosuppression | 5 (2.3 %) | 1 (1.1 %) | 4 (3.1 %) | 0.651 |
Hematological malignancy or solid tumor | 2 (0.9 %) | 0 (0 %) | 2 (1.6 %) | 0.513 |
Tabaco consumption | 63 (52.1 %) | 30 (53.6 %) | 33 (50.8 %) | 0.758 |